Issue 9 2019

2 CORPORATE VISION / Issue 9 2019 Editor’s Note , Welcome to the September issue of Corporate Vision! Your monthly source for all of the latest news, features and insightful pieces from across the corporate landscape. Featured in this month’s issue is the technologically- innovative firm, VirTrial which focuses on pharmaceutical sponsors and CROs that incorporate virtual visits into their clinical trial protocols. The firm’s clinical trials are able to be conducted in a hybrid, decentralised model by enabling some virtual visits and some in-person visits. As such, we profiled the firm to discover more about one of America’s most innovative virtual care platforms for clinical trials. Gracing the cover of the September edition, is one of the leading European-based software vendors, Atempo who provide solutions to protect, store, move and recover all mission-critical data. With influential CEO Luc d’Urso at the helm, we take a closer look at how Atempo is helping to secure the future of digital business. Speaking of leading businesses, Radix provide cutting- edge device management solutions which focus on education, VR/AR and enterprise single-purpose devices. Since their inception, the firm have built a strong reputations for delivering an exceptional service to their diverse client base. As such, we profiled the firm and caught up with Radix’s Marketing Director, Nadav Avni who provided us with a detailed glimpse into the innerworkings of the successful company. This is just a glimpse into this month’s packed edition, and the team here at Corporate Vision hope that you thoroughly enjoy reading this insightful issue that we have created. Finally, we always love hearing from our readers and so if you have any comments, suggestions or ideas please do get in touch! Jessica Daykin, Editor Phone: +44 (0) 203 970 0037 Email: [email protected] Website: www.corporatevision-news.com AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.